当前位置:主页 > 医学论文 > 肿瘤论文 >

PIK3CA基因沉默对阿司匹林抗骨髓瘤作用的影响及机制研究

发布时间:2018-03-09 10:19

  本文选题:PIK3CA基因 切入点:基因沉默 出处:《南昌大学》2015年硕士论文 论文类型:学位论文


【摘要】:目的:1.通过检测阿司匹林(ASA)对人骨髓瘤细胞株RPMI-8226细胞的PIK3CA基因及蛋白表达的影响,探讨PIK3CA基因作为ASA抗骨髓瘤作用靶点的可行性。2.通过沉默PIK3CA基因后检测ASA对RPMI-8226细胞增殖活性的影响,及其下游效应蛋白pAKT的变化,探讨PIK3CA基因在ASA抗骨髓瘤效应中的作用及分子机制。方法:1.采用CCK-8方法,检测不同浓度ASA(0、2.5、5、10mmol/L)处理RPMI-8226细胞24h、48h、72h后细胞增殖变化。2.采用实时荧光定量PCR和Western blot法检测不同浓度ASA对RPMI-8226细胞PIK3CA基因及蛋白表达水平。3.利用siRNA干扰技术,将PIK3CAsiRNA转染RPMI-8226细胞,荧光显微镜下观测细胞转染效果,实时荧光定量PCR检测PIK3CA m RNA表达以检测基因沉默效果。4.采用CCK-8方法,检测沉默PIK3CA基因后,ASA处理后RPMI-8226细胞增殖抑制变化。5.采用流式细胞仪,检测沉默PIK3CA基因后,ASA处理后RPMI-8226细胞凋亡与周期变化。6.采用Western blot法,检测沉默PIK3CA基因后,ASA处理后RPMI-8226细胞AKT与pAKT蛋白表达的变化。结果:1.在2.5~10mmol/L范围内,ASA以剂量依赖性抑制骨髓瘤细胞株RPMI-8226细胞增殖。在24~72h内,ASA对RPMI-8226细胞的增殖抑制率呈时间依赖性。2.在2.5~10mmol/L范围内,ASA以剂量依赖性抑制RPMI-8226细胞的PIK3CA基因与蛋白表达。3.PIK3CAsiRNA转染RPMI-8226细胞后,PIK3CA基因表达下降83.2%,表明基因沉默效果较好。4.与对照组相比,PIK3CAsiRNA转染后,ASA对RPMI-8226细胞的抗增殖活性明显下降,且并不随ASA浓度增大而变化。5.与对照组相比,PIK3CAsiRNA转染后,ASA对RPMI-8226细胞的凋亡诱导活性明显下降。6.与对照组相比,PIK3CAsiRNA转染后,ASA对RPMI-8226细胞的G1期阻滞作用明显下降。7.ASA以剂量依赖性抑制RPMI-8226细胞pAKT蛋白表达,但不影响总AKT蛋白表达。沉默PIK3CA基因后,ASA对RPMI-8226细胞pAKT蛋白抑制作用明显减弱。结论:1.ASA以浓度依赖性抑制骨髓瘤细胞株RPMI-8226细胞的PIK3CA基因及蛋白表达。2.PIK3CA基因沉默可明显减弱ASA对RPMI-8226细胞的增殖抑制、凋亡诱导效应及细胞周期G1期阻滞作用。3.沉默PIK3CA基因显著降低ASA对RPMI-8226细胞AKT磷酸化的抑制作用。4.ASA通过抑制PIK3CA基因及下游效应分子AKT磷酸化而起抗骨髓瘤作用。
[Abstract]:Objective to investigate the effect of aspirin on the expression of PIK3CA gene and protein in human myeloma cell line RPMI-8226. To explore the feasibility of PIK3CA gene as a target of ASA anti-myeloma. (2) to detect the effect of ASA on the proliferation of RPMI-8226 cells and the change of downstream effector protein pAKT by silencing PIK3CA gene. To investigate the role and molecular mechanism of PIK3CA gene in the anti-myeloma effect of ASA. The proliferation of RPMI-8226 cells was detected after treatment with different concentrations of ASA for 24 h or 48 h or 72 h. Real-time quantitative PCR and Western blot were used to detect the PIK3CA gene and protein expression level of RPMI-8226 cells with different concentrations of ASA. PIK3CAsiRNA was transfected into RPMI-8226 cells by siRNA interference technique. The effect of cell transfection was observed under fluorescence microscope, and the expression of PIK3CA m RNA was detected by real-time fluorescence quantitative PCR to detect the effect of gene silencing. 4. CCK-8 method was used to detect the inhibition of RPMI-8226 cell proliferation after PIK3CA gene silencing. 5. Flow cytometry was used. Apoptosis and cell cycle changes of RPMI-8226 cells treated with silencing PIK3CA gene were detected. 6. Western blot assay was used to detect apoptosis and cell cycle change of RPMI-8226 cells. The changes of AKT and pAKT protein expression in RPMI-8226 cells treated with silencing PIK3CA gene were detected. Results 1. The proliferation of RPMI-8226 cells was inhibited in a dose-dependent manner in the range of 2.510 mmol / L. The inhibitory rate of AKT and pAKT protein on RPMI-8226 cells was observed within 2472 h. In a dose-dependent manner, the expression of PIK3CA gene and protein in RPMI-8226 cells was inhibited in a dose-dependent manner. 3. PIK3CAsiRNA transfection into RPMI-8226 cells decreased the expression of PIK3CA gene by 83.2%, which indicated that gene silencing effect was better than that of control group. The antiproliferative activity of RPMI-8226 cells decreased significantly. Compared with the control group, the apoptosis-inducing activity of PIK3CAsiRNA on RPMI-8226 cells decreased significantly. 6. Compared with the control group, the G 1 phase arrest of RPMI-8226 cells was significantly decreased by PIK3CAsiRNA transfection. The expression of pAKT protein in RPMI-8226 cells was inhibited in a dependent manner. After silencing the PIK3CA gene, the inhibition of pAKT protein in RPMI-8226 cells was obviously weakened. Conclusion: 1. The inhibition of PIK3CA gene and protein expression in RPMI-8226 cell line by ASA in a concentration dependent manner. 2. PIK3CA gene silencing can make it clear. The inhibitory effect of ASA on the proliferation of RPMI-8226 cells was significantly decreased. Apoptosis-induced effect and G1 phase arrest of cell cycle .3. silencing PIK3CA gene significantly reduced the inhibitory effect of ASA on AKT phosphorylation in RPMI-8226 cells. 4. ASA played an anti-myeloma effect by inhibiting the phosphorylation of PIK3CA gene and downstream effector molecule AKT.
【学位授予单位】:南昌大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R733.3

【参考文献】

相关期刊论文 前3条

1 周新科;何璐;梁敏;刘季芳;;壳聚糖纳米粒介导的PIK3CA基因干扰对胃癌细胞侵袭转移能力的影响[J];南方医科大学学报;2014年10期

2 Roberto Ria;Antonia Reale;Angelo Vacca;;Novel agents and new therapeutic approaches for treatment of multiple myeloma[J];World Journal of Methodology;2014年02期

3 刘恩菊 ,项永兵 ,金凡 ,周淑贞 ,孙璐 ,方茹蓉 ,阮志贤 ,高立峰 ,高玉堂;上海市区恶性肿瘤发病趋势分析(1972~1999年)[J];肿瘤;2004年01期

相关博士学位论文 前1条

1 丁江华;阿司匹林对多发性骨髓瘤的抗肿瘤效应及其增强硼替佐米细胞毒作用的分子机制研究[D];南昌大学;2014年



本文编号:1588107

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/zlx/1588107.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户9392d***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com